Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112675920B reveals a novel monochiral ruthenium catalyst enabling efficient asymmetric hydrogenation and kinetic resolution for high-purity pharmaceutical intermediates.
Patent CN116640146A reveals efficient Pd-catalyzed synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and reliable supply chain scalability.
Patent CN113307778A reveals a mild Mo-Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN110183443A reveals a novel Rh-catalyzed oxidative coupling for high-purity indolo[3,2-c]quinoline. Achieve cost reduction in pharma intermediate manufacturing with this efficient, halogen-free route.
Patent CN102351778A details a high-yield synthesis of Arbidol HCl via iron-mediated cyclization, offering significant cost reduction in pharmaceutical manufacturing and scalable supply chain solutions.
Novel patent CN102898388B details an iron-catalyzed vinylation for benzo[alpha]phenazines. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN105837539B details mild Selectfluor fluorination for high-purity benzofuran derivatives offering significant cost and supply chain advantages for global pharmaceutical manufacturers.
Novel anti-tumor compound synthesis with mild conditions. Offers significant cost reduction and scalable production capabilities for global pharmaceutical intermediate supply chains seeking reliable partners.
Patent CN113045489B details a novel Pd-catalyzed route to 3-arylquinolin-2(1H)ones using benzisoxazole, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN114195711B details a novel Pd-catalyzed carbonylation route for quinoline-4(1H)-one intermediates, offering simplified processing and enhanced supply chain reliability for pharmaceutical manufacturing.
Patent CN102358715B details a low-toxicity cyanation method using potassium ferrocyanide, offering significant cost reduction and safety advantages for pharmaceutical intermediate manufacturing.
Patent CN116496251A reveals cobalt-catalyzed synthesis for high-purity pharmaceutical intermediates. Achieve substantial cost reduction and supply chain reliability.
Patent CN112480015B reveals a novel Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN103613551A details a novel rare earth-catalyzed route for 1,5-disubstituted-1,2,3-triazoles, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN111423381B reveals a mild palladium-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering significant cost reduction in API manufacturing and scalable production.
Novel MOF-Cu catalyzed Ugi reaction enables efficient synthesis of isoindolinone dipeptides, offering cost reduction and scalable production for reliable agrochemical intermediate suppliers.
Patent CN112538054B reveals a novel Pd-catalyzed carbonylation route for 1,2,4-triazole-3-one synthesis, offering high yields and broad substrate tolerance for pharmaceutical manufacturing.
Novel Pd-catalyzed one-pot synthesis offers high efficiency and scalable production for pharmaceutical intermediates supply chain optimization.
Patent CN115353511A details a safe, multicomponent palladium-catalyzed synthesis of carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and scalable production.
Novel copper-catalyzed method for highly functionalized beta-lactams. Improves yield and enantioselectivity for antibiotic intermediates.